Concepedia

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life

Carlo Lombardi, Diego Bagnasco, Cristiano Caruso, Francesco Menzella, Manlio Milanese, Gianenrico Senna, Giorgio Walter Canonica, Giovanni Passalacqua

Pulmonary Pharmacology & Therapeutics · 2018 · 17 citations · 11 references

DOI

Concepts

References

11

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung, Sally E. Wenzel, Jan Brożek et al. · European Respiratory Journal · 2013 · 3.9K citations · Full text

, , +13

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Héctor Ortega, Mark C. Liu, Ian Pavord et al. · New England Journal of Medicine · 2014 · 2.3K citations · Full text

, , +16

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

, , +14

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon et al. · New England Journal of Medicine · 2009 · 1.9K citations · Full text

, , +11

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Elisabeth H. Bel, Sally E. Wenzel, Philip J. Thompson et al. · New England Journal of Medicine · 2014 · 1.6K citations

, , +17